XRN · Chiron Real Estate Inc.
$37.03
+0.16 (+0.43%)
At close · Aug 20
Market Cap
$490.20M
Shares
13.24M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$37.03
Open$36.67
Day$36.37–37.32
Since split$30.15–38.10
Avg vol 30d84K
Short int825K · 6.2% float · 11.4d
Short vol76%
Last earningsAug 6, 2026
DataSep 2025–Aug 2026
Filing10-Q · Aug 10
Raw chart and full-history price indicators begin at the captured split on Sep 22, 2025; bars on opposite sides are not compared.
The closing range begins at the captured split on Sep 22, 2025.
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 10, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Neutral
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+6%
above
Price vs 50-day avg
+1%
above
RSI (14)
55
neutral
MACD trend
Positive
52-week position
87%
near high
Momentum
relative strength
1-month return
0%
trailing
6-month return
+1%
trailing
YTD return
+10%
this year
Relative strength
−10%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $37 › 200d $35 — 50d above 200d
Institutional flow
Accumulating
+5% holders QoQ · +32 funds added
Insider flow
Accumulating
Net +$2.6M over 90 days · 0% sells
Short interest
Rising
6.24% of float · ▲ +0.6% MoM · 11.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
170 holders — near 1-yr high, broad support
Squeeze score
70
elevated · 0–100
Fundamentals
Revenue growth
+7%
Y/Y
EPS growth
−1617%
Y/Y
Free cash flow
$41.8M
Buyback
$44.0M
remaining
Balance sheet
$7.9M
net cash
Quant / Vol
risk profile
Volatility
30%
annualized · 1-yr
Max drawdown
−21%
past year
ATR
2.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jun 30, 2025
per year
Dividend reduction is expected to generate
up to $17M
next 24 to 36 months
East Orange property stabilized occupancy
at least 90%
Prior guidance
period ended
· from the 8-K filed Nov 4, 2025
AFFO per share and unit
· full year 2025
$4.50 – $4.60
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+6%
Bullish
Price vs 50-day avg
+1%
Bullish
RSI (14)
55
Neutral
MACD trend
Positive
Bullish
52-week position
87%
Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $37 › 200d $35 — 50d above 200d
Institutional flow
Accumulating
+5% holders QoQ · +32 funds added
Insider flow
Accumulating
Net +$2.6M over 90 days · 0% sells
Short interest
Rising
6.24% of float · ▲ +0.6% MoM · 11.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
170 holders — near 1-yr high, broad support
Price context
position in its range since split · 2025-09-22
Range low $30
Now $37 · 87%
Range high $38
vs 200-day avg +6%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDAre non-GAAP | $26.12M | Three Months Ended June 30 | — |
| Adjusted EBITDAre, Annualized non-GAAP | $104.5M | 2Q 2026 | — |
| Annualized Cash NOI non-GAAP | $97.5M | Pro Forma Portfolio | — |
| Assets | 181 | Pro Forma Portfolio | — |
| Average Asset Size | 25K | Pro Forma Portfolio | — |
| Average Homes / Community | 156 | Pro Forma Portfolio | — |
| Average RevPOR | $10,800 | Pro Forma Portfolio | — |
| Capital Expenditures / Cash NOI | 11.3% | 2Q 2026 | — |
| Cash NOI non-GAAP | $30.09M | Three Months Ended June 30 | — |
GAAP → non-GAAP reconciliationGAAP NOI 29.82M
+150K Amortization of above (below) market leases, net
+122K Straight line deferred rental revenue
-2K Proportionate share of unconsolidated joint venture adjustments
= Cash NOI 30.09M
|
|||
| Cash NOI (Annualized) non-GAAP | $120.3M | Q2 2026 | — |
| Core FFO attributable to common stockholders and noncontrolling interest non-GAAP | $15.1M | Three Months Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP FFO attributable to common stockholders and noncontrolling interest 12.74M
+150K Amortization of above (below) market leases, net
+122K Straight line deferred rental revenue
+1.38M Stock-based compensation expense
+707K Amortization of debt issuance costs and other
+0K Severance and transition related expense
+2K Other adjustments from unconsolidated joint ventures
= Core FFO attributable to common stockholders and noncontrolling interest 15.1M
|
|||
| Core FFO Per Share and Unit non-GAAP | $1.04 | 2Q 2026 | — |
| EBITDAre non-GAAP | $24.59M | Three Months Ended June 30 | — |
| FAD attributable to common stockholders and noncontrolling interest non-GAAP | $11.7M | Three Months Ended June 30 | — |
GAAP → non-GAAP reconciliationGAAP Core FFO attributable to common stockholders and noncontrolling interest 15.1M
-762K Tenant improvements
-367K Leasing commissions
-2.27M Building capital
= FAD attributable to common stockholders and noncontrolling interest 11.7M
|
|||
| FFO attributable to common stockholders and noncontrolling interest non-GAAP | $12.74M | Three Months Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income 72.28M
-2.98M Preferred stock dividends
+15.25M Depreciation and amortization expense
+73K Depreciation and amortization expense from unconsolidated joint ventures
-71.88M Gain on sale of investment properties
= FFO attributable to common stockholders and noncontrolling interest 12.74M
|
|||
| FFO Per Share and Unit non-GAAP | $0.88 | 2Q 2026 | — |
| Implied Portfolio Cap Rate | 7.8% | Q2 FY2026 | — |
| leasable square feet | 4.6M | Q2 2026 | — |
| leased occupancy rate | 95% | Q2 2026 | — |
| Leased/Occupied (Outpatient Medical) | 94.7% | 2Q 2026 | — |
| Leverage | 39.9% | As of June 30, 2026 | — |
| Net Absorption (GLA) | -6,481 | 2Q 2026 | — |
| NOI non-GAAP | $29.82M | Three Months Ended June 30 | — |
GAAP → non-GAAP reconciliationGAAP Net income 72.28M
+5.22M General and administrative
+15.28M Depreciation and amortization expense
+8.81M Interest expense
-71.88M Gain on sale of investment properties
+114K Proportionate share of unconsolidated joint venture adjustments
= NOI 29.82M
|
|||
| Occupancy | 95% | Pro Forma Portfolio | — |
| OM Square Feet | 4.6M | Q2 2026 | — |
| Outpatient Medical GLA | 4,644,832 | 2Q 2026 | — |
| Outpatient Medical Leased Rate | 94.7% | 2Q 2026 | — |
| Outstanding Shares at Quarter End | 14.5M | Q2 FY2026 | — |
| Portfolio Area | 4.6M | Pro Forma Portfolio | — |
| Property Count | 184 | Q2 2026 | — |
| Same-Property Cash NOI non-GAAP | $24.11M | Three Months Ended June 30 | +0.8% |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Cash NOI 30.09M
-5.03M Assets not held for all periods
+0K Lease termination fees
-948K Joint ventures and other income
= Same-Property Cash NOI 24.11M
|
|||
| Same-Property Cash NOI growth non-GAAP | 0.8% | 2Q 2026 | — |
| SHOP Homes | 292 | Q2 2026 | — |
| Tenant Retention | 61% | 2Q 2026 | — |
| The Landing occupancy | 93% | As of June 30, 2026 | — |
| The Riviera occupancy | 23% | As of June 30, 2026 | — |
| Total Homes | 467 | Pro Forma Portfolio | — |
| Total Liquidity | $269.66M | 2Q 2026 | — |
| Weighted average annual base rent escalations | 2.1% | Q2 2026 | — |
| Weighted average interest rate on total debt | 4.56% | As of June 30, 2026 | — |
| Weighted average lease term | 4.4 | Q2 2026 | — |
| Weighted average lease term (WALT) | 5.2 | year end 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
XRN
this stock
Chiron Real Estate Inc.
|
$490.20M | +9.8% | +6.8% | — | 6.2% |
|
WELL
Welltower Inc.
|
$167.58B | +27.9% | +35.6% | 118.1 | 2.5% |
|
VTR
Ventas, Inc.
|
$47.54B | +19.8% | +18.5% | 171.6 | 4.6% |
|
DOC
Healthpeak Properties, Inc.
|
$14.24B | +31.8% | +4.5% | 59.0 | 3.5% |
|
OHI
Omega Healthcare Investors Inc
|
$14.22B | +5.4% | +13.2% | 16.7 | 4.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
Raw-price comparisons begin at the captured split on Sep 22, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XRN | +1.2% | -0.2% | +1.2% | +4.3% | +9.8% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +3.2% | -3.6% | -10.0% | +2.2% | -2.1% |
Capital returns
Latest dividend
$0.16
/ share · ex Aug 20, 2026
Declared · upcoming
$0.16
/ share · ex Sep 21, 2026
Paid (TTM)
$2.73
/ share · 8 payouts
Dividend yield (TTM, derived)
7.37%
Buyback program
· as of Jun 30, 2026
Authorized
$50.00M
Spent (derived)
$6.00M
Remaining
$44.00M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1533615
CUSIP
37954A303
13F (30d)
152 filings
151 filers
Visit website
Investor relations